Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123926) titled 'A clinical trial to evaluate the safety, tolerability, and preliminary anti-tumor activity of a novel therapeutic tumor vaccine in patients with advanced malignant solid tumors' on May 1.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Advanced malignant solid tumor
Intervention:
YMN101(Part A1):Novel Therapeutic Cancer Vaccine
YMN101 and Regorafenib(Part A2):Novel Therapeutic Cancer Vaccine
YMN102(Part B1):Novel Therapeutic Cancer Vaccine
YMN103(Part C1):Novel Therapeutic Cancer Vaccine
YMN104(Part D1):Novel Therapeutic Cancer Vac...